Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
FUTURA MEDICAL Aktie jetzt für 0€ handeln | |||||
11.07. | Futura Medical cannot explain share price increase after board shuffle | 4 | Alliance News | ||
11.07. | Futura Medical notes unexplained share price increase | 6 | Investing.com | ||
11.07. | Futura Medical PLC - Share price movement | 1 | RNS | ||
10.07. | AIM Market Roundup: Futura Medical, Norman Broadbent, Dekel Agri-Vision | 3 | The Armchair Trader | ||
08.07. | Futura Medical PLC - Board Changes | 1 | RNS | ||
20.06. | Futura Medical PLC - Result of AGM | 4 | RNS | ||
27.05. | Futura Medical plant Hauptversammlung für den 19. Juni 2025 | 6 | Investing.com Deutsch | ||
27.05. | Futura Medical schedules AGM for June 19, 2025 | 2 | Investing.com | ||
27.05. | Futura Medical PLC - Notice of AGM and availability of Annual Report | 1 | RNS | ||
24.04. | Futura Medical appoints Panmure Liberum as sole broker | 8 | Investing.com | ||
24.04. | Futura Medical PLC - Change of Broker | 5 | RNS | ||
15.04. | Futura Medical PLC - Results for the Year ended 31 December 2024 | 8 | RNS | ||
10.04. | Futura Medical PLC - Notice of Results and Investor Presentation | 5 | RNS | ||
31.03. | Futura Medical PLC - Board Appointment | 4 | RNS | ||
30.01. | AIM WINNERS & LOSERS: Kromek wins deal; Futura Medical warns on profit | 15 | Alliance News | ||
30.01. | Futura Medical PLC - FY24 Trading Update and FY25 Outlook | 9 | RNS |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVO NORDISK | 61,04 | +0,15 % | Netflix, Netramark, Novo Nordisk - Positive Zeichen | Von wegen: "Sell in may, and go away". Durch die altbekannte Börsenweisheit hätten Anleger im Jahr 2025 so manche Gewinne verpasst. Vielmehr stehen sowohl die global wichtigsten Indizes wie Dow Jones... ► Artikel lesen | |
GILEAD SCIENCES | 98,96 | 0,00 % | Gilead Sciences, Inc.: Gilead Receives Positive CHMP Opinions Under Accelerated Review From European Medicines Agency for Twice-Yearly Lenacapavir for HIV Prevention | - If Approved, Lenacapavir Would Be the First and Only Twice-Yearly HIV PrEP Option in the European Union - - Positive Opinion Also Received for EMA's EU-M4all Procedure, Designed to Facilitate... ► Artikel lesen | |
AURORA CANNABIS | 4,100 | -0,24 % | Unglaubliche Prognose für Montag setzt Aurora Cannabis Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
CANOPY GROWTH | 0,952 | -0,94 % | Canopy Growth Corp (2): Canopy Growth to release fiscal Q1 2026 results Aug. 8 | ||
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
TILRAY BRANDS | 0,580 | -0,92 % | A Peek at Tilray Brands' Future Earnings | ||
VERTEX PHARMACEUTICALS | 399,30 | -0,15 % | Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis | ||
INNOCAN PHARMA | 0,146 | -1,02 % | Einzigartig! Innocan Pharma mit dem Gamechanger-Vorteil! | ||
TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
BIOTEST | 30,000 | +1,35 % | EQS-News: Biotest AG: Hauptversammlung beschließt Dividendenausschüttung | EQS-News: Biotest AG
/ Schlagwort(e): Hauptversammlung
Biotest AG: Hauptversammlung beschließt Dividendenausschüttung
02.07.2025 / 18:08 CET/CEST
Für den Inhalt der... ► Artikel lesen | |
CRONOS GROUP | 1,712 | -2,17 % | Cronos Group Inc: Cronos Group to hold Q2 2025 results call Aug. 7 | ||
SYNBIOTIC | 2,965 | -0,67 % | SYNBIOTIC SE: Update von der mwb-Konferenz: Diversifiziertes Geschäftsmodell gewinnt an Dynamik; mwb research empfiehlt KAUFEN | Auf der mwb research Health Care Conference bekräftigten CEO Daniel Kruse und sein Team den strategischen Fokus von SYNBIOTIC auf ein plattformbasiertes Buy-and-Build-Modell in wachstumsstarken Cannabis-... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
EYEPOINT PHARMACEUTICALS | 8,586 | -3,74 % | EyePoint Pharmaceuticals, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
EDWARDS LIFESCIENCES | 67,54 | -0,84 % | Edwards Lifesciences Corp. Reports Retreat In Q2 Income | WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) reported earnings for second quarter that Drops, from the same period last yearThe company's bottom line totaled $333.2 million, or $0.56... ► Artikel lesen |